Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior
Ahmad Y. Sheikh, Alessandra Mattei, Rajni M. Bhardwaj, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 42, pp. 17479-17491
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Macrocycles in Drug Discovery─Learning from the Past for the Future
Diego García Jiménez, Vasanthanathan Poongavanam, Jan Kihlberg
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5377-5396
Open Access | Times Cited: 120
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
Edward Price, Manuel Weinheimer, Alexey Rivkin, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5683-5698
Closed Access | Times Cited: 23
Molecular chameleons in drug discovery
Vasanthanathan Poongavanam, Lianne H. E. Wieske, Stefan Peintner, et al.
Nature Reviews Chemistry (2023) Vol. 8, Iss. 1, pp. 45-60
Closed Access | Times Cited: 27
Advancing New Chemical Modalities into Clinical Studies
María‐Jesús Blanco, Kevin M. Gardinier, Mark Namchuk
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 11, pp. 1691-1698
Open Access | Times Cited: 34
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
Sven Stegemann, Chris Moreton, Sami Svanbäck, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103344-103344
Open Access | Times Cited: 33
Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals
Srinivasulu Aitipamula, Geetha Bolla
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3121-3143
Closed Access | Times Cited: 5
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
James Cregg, Kristóf Póta, Aidan C.A. Tomlinson, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED
Guanhong Bu, Emma Danelius, Lianne H. E. Wieske, et al.
Advanced Biology (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 4
Influence of Solvent Selection on the Crystallizability and Polymorphic Selectivity Associated with the Formation of the “Disappeared” Form I Polymorph of Ritonavir
Chang Wang, Cai Y., Richard S. Hong, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3525-3539
Open Access | Times Cited: 3
High-Throughput SFC-MS/MS Method to Measure EPSA and Predict Human Permeability
Yue-Ting Wang, Edward Price, Mei Feng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13765-13777
Closed Access | Times Cited: 3
Efficient Crystal Structure Prediction for Structurally Related Molecules with Accurate and Transferable Tailor-Made Force Fields
Alessandra Mattei, Richard S. Hong, H. Dietrich, et al.
Journal of Chemical Theory and Computation (2022) Vol. 18, Iss. 9, pp. 5725-5738
Open Access | Times Cited: 16
MicroED as a Powerful Tool for Structure Determination of Macrocyclic Drug Compounds Directly from Their Powder Formulations
Emma Danelius, Guanhong Bu, Lianne H. E. Wieske, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 12, pp. 2582-2589
Open Access | Times Cited: 9
Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds
Lianne H. E. Wieske, Yoseph Atilaw, Vasanthanathan Poongavanam, et al.
Chemistry - A European Journal (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 15
Challenges in Permeability Assessment for Oral Drug Product Development
Mirko Koziolek, Patrick Augustijns, Constantin Berger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 8
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit and Returned to Earth
Haley Bauser, Pamela A. Smith, Stephan D. Parent, et al.
(2024)
Open Access | Times Cited: 2
Simulation Reveals the Chameleonic Behavior of Macrocycles
Daniel Sethio, Vasanthanathan Poongavanam, Ruisheng Xiong, et al.
Journal of Chemical Information and Modeling (2022) Vol. 63, Iss. 1, pp. 138-146
Open Access | Times Cited: 13
A quaternary solid-form of ritonavir: an oxalate salt oxalic acid co-crystal acetone solvate
Chang Wang, Thomas D. Turner, Cai Y., et al.
CrystEngComm (2023) Vol. 25, Iss. 12, pp. 1782-1791
Open Access | Times Cited: 7
Distinct Hybrid Hydrates of Paritaprevir: Combined Experimental and Computational Assessment of their Hydration–Dehydration Behavior and Implications for Regulatory Controls
Richard S. Hong, Rajni M. Bhardwaj, Rodger F. Henry, et al.
Crystal Growth & Design (2021) Vol. 22, Iss. 1, pp. 726-737
Closed Access | Times Cited: 15
Exploring the CSD Drug Subset: An Analysis of Lattice Energies and Constituent Intermolecular Interactions for the Crystal Structures of Pharmaceuticals
Cai Y., Alexandru A. Moldovan, Andrew G. P. Maloney, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 435-445
Open Access | Times Cited: 10
Origins and Implications of Extraordinarily Soft Crystals in a Fixed-Dose Combination Hepatitis C Regimen
Rajni M. Bhardwaj, Raimundo Ho, Yue Gui, et al.
Crystal Growth & Design (2022) Vol. 22, Iss. 7, pp. 4250-4259
Closed Access | Times Cited: 9
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit
Haley Bauser, Pamela A. Smith, Stephan D. Parent, et al.
(2024)
Open Access | Times Cited: 1
Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit
Haley Bauser, Pamela A. Smith, Stephan D. Parent, et al.
(2024)
Open Access | Times Cited: 1
Unraveling the complexity of amorphous solid as direct ingredient for conventional oral solid dosage form: The story of Elagolix Sodium
Raimundo Ho, Richard S. Hong, Joseph Kalkowski, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124656-124656
Closed Access | Times Cited: 1
Packing Preferences of Chalcones: A Model Conjugated Pharmaceutical Scaffold
Louise S. Price, Sarah L. Price
Crystal Growth & Design (2022) Vol. 22, Iss. 3, pp. 1801-1816
Open Access | Times Cited: 8
A data-driven and topological mapping approach for the a priori prediction of stable molecular crystalline hydrates
Richard S. Hong, Alessandra Mattei, Ahmad Y. Sheikh, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 43
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top